Skip to main content
. 2010 Nov 22;3(3):423–427. doi: 10.1159/000322675

Fig. 2.

Fig. 2

Computerized perimetry. a First visual field performed after 1 month without oxaliplatin chemotherapy showed a concentric defect with deeply diminished light sensitivity. BCVA was 20/30 in the RE and 15/25 in the LE. b After 8 months without oxaliplatin, the visual field shows practically complete recovery of light sensitivity in both eyes, with only mild residual defects remaining. BCVA was 20/20 in both eyes.